4//SEC Filing
Brown Michael J 4
Accession 0001437749-25-011068
CIK 0001645469other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:27 PM ET
Size
10.3 KB
Accession
0001437749-25-011068
Insider Transaction Report
Form 4
O'Halloran Thomas V.
Other
Transactions
- Sale
Common Stock
2025-04-02$35.00/sh−33,334$1,166,690→ 822,255 total
Mazar Andrew Paul
Other
Transactions
- Sale
Common Stock
2025-04-02$35.00/sh−33,334$1,166,690→ 822,255 total
Tactic Pharma LLC
10% Owner
Transactions
- Sale
Common Stock
2025-04-02$35.00/sh−33,334$1,166,690→ 822,255 total
Robinson Chandler
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2025-04-02$35.00/sh−33,334$1,166,690→ 822,255 total
BROWN MICHAEL J
Other
Transactions
- Sale
Common Stock
2025-04-02$35.00/sh−33,334$1,166,690→ 822,255 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.86, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.
Documents
Issuer
Monopar Therapeutics
CIK 0001645469
Entity typeother
Related Parties
1- filerCIK 0001035909
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:27 PM ET
- Size
- 10.3 KB